Cancer research capabilities
The Foundation conducts independently funded international research with the private sector to evaluate promising new agents.
Source: LinkedIn company description · Retrieved October 13, 2026
The NSABP Foundation is a not-for-profit academic research organization conducting breast and colorectal cancer research.
Its stated goal is to improve outcomes for cancer patients through therapeutic and prevention modalities. Its research sites include medical centers, university hospitals, oncology practice groups, and health maintenance organizations in the United States, Canada, and Ireland.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The Foundation conducts clinical studies in partnership with industry.
The Foundation conducts independently funded international research with the private sector to evaluate promising new agents.
Source: LinkedIn company description · Retrieved October 13, 2026
Its capabilities span pre-clinical research through phase clinical trials focused on biomarker-driven studies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026, September 26, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.